Figures computed from official regulatory filings — .
Analysttarget 4 USD (+217%) · consensus 3/5 · 0 buy · 2 hold · 0 sell
Ownershipinsiders 22.26% · institutions 13.41% · short 2.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for LISATA THERAPEUTICS, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
57 buys36 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Nisco James | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nisco James | Other | $4.2K | SEC |
| Imam Tariq | Other | $1.5K | SEC |
| Buck Kristen K | Other | $5.9K | SEC |
| Nisco James | Other | $2.2K | SEC |
| Imam Tariq | Other | $2.8K | SEC |
| Buck Kristen K | Other | $6.3K | SEC |
| Imam Tariq | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Buck Kristen K | Other | $4.2K | SEC |
| HENSON HEIDI | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazzo David J | Other | $20.7K | SEC |
| Imam Tariq | Other | $1K | SEC |
| Mazzo David J | Other | $20.7K | SEC |
| AZAB MOHAMMADtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Buck Kristen K | Other | $5.9K | SEC |
| Nisco James | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazzo David J | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mazzo David J | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Imam Tariq | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nisco James | Other | $1.5K | SEC |
| BROWN GREGORY B | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Buck Kristen K | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schwalm Cynthia | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nisco James | Other | $4.2K | SEC |
| Mazzo David J | Other | $24.1K | SEC |